Content Library
Year/Month in Review

NEW!
2021: January in Review

NEW!
2020: Year in Review
Survey Results

NEW!
CAR-TCR Industry Survey 2020

NEW!
CAR-TCR Digital Week Poll Results

CAR-TCR Summit Survey 2020 - Results
Post-Event Reports

NEW!
2020 ASH Post-Event Report
Year in Review

NEW!
2020: Year in Review
Reading Lists

NEW!
Christmas Reading List
Interviews

NEW!
Introducing Captain T Cell
Felix Lorenz
Webinars
NEW!
Bringing It All Together – From Early Technology Evaluations to Commercial Approval
There is more than meets the eye with cell therapy manufacturing than just scalability. Listen to our discussion with Lonza, ZIOPHARM, MSKCC and Stanford Center for Cancer Cell Therapy on the lessons learned from early technology evaluations to the commercial approval of immunotherapies.
Magazine

CAR-TCR Magazine
Presentations

Key Takeaways from the 'Strategic Dive' Workshops at CAR-TCR Boston 2019

White Paper: Advancing Next Generation Therapeutics
By Sartorius brands; IncuCyte & intellicyt

How to Generate Optimal-Affinity TCRs for the Clinic?
Elisa Kieback,
CEO,
T-Knife

Development of First Manufacturing Process to Produce CAR-Treg Cells for Clinical Use
Pierre Heimendinger,
VP Pharmaceutical Development,
TxCell

Regenerative Medicines and Cell Therapy Products: Is the NICE Therapy Products: Is the NICE Therapy
Grace Hampson,
Senior Economist
The Office of Health Economics